2022
DOI: 10.1016/j.stemcr.2022.06.007
|View full text |Cite
|
Sign up to set email alerts
|

Autism NPCs from both idiopathic and CNV 16p11.2 deletion patients exhibit dysregulation of proliferation and mitogenic responses

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
7
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
3
2

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(9 citation statements)
references
References 0 publications
2
7
0
Order By: Relevance
“…The current reports on the effects of 16p11.2 deletion on cortical NPC proliferation are few and variable, leaving the effects of this CNV on the ventral telencephalon largely unexplored. Enhanced proliferation (Connacher et al, 2022, Pucilowska et al, 2015, no difference in NPC proliferation rates (Deshpande et al, 2017, Roth et al, 2020 or a reduction in NPC proliferation (Urresti et al, 2021), as observed in our ventral progenitors, have been reported, further highlighting the increased variability associated with this deletion.…”
Section: Variability As a Hallmark Of 16p112 Deletionsupporting
confidence: 64%
See 1 more Smart Citation
“…The current reports on the effects of 16p11.2 deletion on cortical NPC proliferation are few and variable, leaving the effects of this CNV on the ventral telencephalon largely unexplored. Enhanced proliferation (Connacher et al, 2022, Pucilowska et al, 2015, no difference in NPC proliferation rates (Deshpande et al, 2017, Roth et al, 2020 or a reduction in NPC proliferation (Urresti et al, 2021), as observed in our ventral progenitors, have been reported, further highlighting the increased variability associated with this deletion.…”
Section: Variability As a Hallmark Of 16p112 Deletionsupporting
confidence: 64%
“…Studies in 16p11.2 mouse models and patient derived NPCs have demonstrated enhanced cortical progenitor proliferation (Pucilowska et al, 2015, (Connacher et al, 2022, whereas other studies utilising human iPSC-derived cortical NPCs showed no difference in NPC proliferation rates (Deshpande et al, 2017, Roth et al, 2020. Therefore, we investigated whether the deletion affects the cell cycle of ventral progenitors within the outer SOX2+ peripheral region of the organoids, since control organoids formed very few rosettes.…”
Section: P112 Deletion Organoids Exhibited Increased Cell Cycle Lengt...mentioning
confidence: 99%
“…The current reports on the effects of 16p11.2 deletion on cortical NPC proliferation are few and variable, leaving the effects of this CNV on the ventral telencephalon largely unexplored. Enhanced proliferation ( Connacher et al, 2022 ; Pucilowska et al, 2015 ), no difference in NPC proliferation rates ( Deshpande et al, 2017 ; Roth et al, 2020 ) or a reduction in NPC proliferation ( Urresti et al, 2021 ), as observed in our ventral progenitors, have been reported, further highlighting the increased variability associated with this deletion.…”
Section: Discussionsupporting
confidence: 49%
“…Studies in 16p11.2 mouse models and patient-derived NPCs have demonstrated enhanced cortical progenitor proliferation ( Pucilowska et al, 2015 ; Connacher et al, 2022 ), whereas other studies using human iPSC-derived cortical NPCs showed no difference in NPC proliferation rates ( Deshpande et al, 2017 ; Roth et al, 2020 ). Therefore, we investigated whether the deletion affects the cell cycle of ventral progenitors within the outer SOX2 + peripheral region of the organoids, as control organoids formed very few rosettes.…”
Section: Resultsmentioning
confidence: 94%
“…Indeed, altered regulation of proliferation has been demonstrated to cause defects in the progenitors’ fate and, ultimately, neuronal development trajectories (Pilaz et al, 2016). In several cellular models of ASD, both hyper- and hypo-proliferation of neural progenitors have been documented (Connacher et al, 2022; Marchetto et al, 2017; Mowat et al, 2003; Zucco et al, 2018).…”
Section: Discussionmentioning
confidence: 99%